Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R F Storey

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Platelets|July 17, 2001
The P2Y12 receptor as a therapeutic target in cardiovascular diseaseR F Storey
Clinical and Laboratory Haematology|January 26, 2000
Laboratory investigation of platelet functionR F Storey, S Heptinstall
Journal of the Royal College of Physicians of London|January 16, 1998
Electrocardiogram interpretation as a basis for thrombolysisR F Storey, J M Rowley
Postgraduate Medical Journal|March 16, 2004
Antiplatelet therapy in cardiovascular diseaseM W H Behan, R F Storey
Circulation|October 20, 1998
Differential effects of glycoprotein IIb/IIIa antagonists on platelet microaggregate and macroaggregate formation and effect of anticoagulant on antagonist potency. Implications for assay methodology and comparison of different antagonistsR F Storey, R G Wilcox, S Heptinstall
Diabetologia|January 17, 2008
Aspirin resistance and diabetes mellitusR Ajjan, R F Storey, P J Grant
Thrombosis and Haemostasis|March 8, 2013
Platelet function testing and prediction of procedural bleeding riskE L Grove, R Hossain, R F Storey
Platelets|October 25, 2001
Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole bloodR F Storey, L J Newby, S Heptinstall
Thrombosis and Haemostasis|April 20, 2001
Open multicentre study of the P2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndromesR F Storey, K G Oldroyd, R G Wilcox
Thrombosis and Haemostasis|September 12, 2014
Can we improve the efficacy of low-dose aspirin?E L Grove, R F Storey, S D Kristensen
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Platelets|July 17, 2001
The P2Y12 receptor as a therapeutic target in cardiovascular diseaseR F Storey
Clinical and Laboratory Haematology|January 26, 2000
Laboratory investigation of platelet functionR F Storey, S Heptinstall
Journal of the Royal College of Physicians of London|January 16, 1998
Electrocardiogram interpretation as a basis for thrombolysisR F Storey, J M Rowley
Postgraduate Medical Journal|March 16, 2004
Antiplatelet therapy in cardiovascular diseaseM W H Behan, R F Storey
Circulation|October 20, 1998
Differential effects of glycoprotein IIb/IIIa antagonists on platelet microaggregate and macroaggregate formation and effect of anticoagulant on antagonist potency. Implications for assay methodology and comparison of different antagonistsR F Storey, R G Wilcox, S Heptinstall
Diabetologia|January 17, 2008
Aspirin resistance and diabetes mellitusR Ajjan, R F Storey, P J Grant
Thrombosis and Haemostasis|March 8, 2013
Platelet function testing and prediction of procedural bleeding riskE L Grove, R Hossain, R F Storey
Platelets|October 25, 2001
Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole bloodR F Storey, L J Newby, S Heptinstall
Thrombosis and Haemostasis|April 20, 2001
Open multicentre study of the P2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndromesR F Storey, K G Oldroyd, R G Wilcox
Thrombosis and Haemostasis|September 12, 2014
Can we improve the efficacy of low-dose aspirin?E L Grove, R F Storey, S D Kristensen
Pageof 3